Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma

Patients who are on drugs that suppress the immune system are more susceptible to infection than healthy individuals. Chicken pox and measles , for example, can have a more serious or even fatal course in susceptible pediatric patients or adults on immunosuppressant doses of corticosteroids. In pediatric or adult patients who have not had these diseases, particular care should be taken to avoid exposure. How the dose, route, and duration of corticosteroid administration affects the risk of developing a disseminated infection is not known. The contribution of the underlying disease and/or prior corticosteroid treatment to the risk is also not known. If exposed, therapy with varicella zoster immune globulin (VZIG) or pooled intravenous immunoglobulin (IVIG), as appropriate, may be indicated. If exposed to measles, prophylaxis with pooled intramuscular immunoglobulin (IG) may be indicated. (See the respective package inserts for complete VZIG and IG prescribing information.) If chicken pox develops, treatment with antiviral agents may be considered.

Certain drugs such as troleandomycin (TAO), erythromycin ( Ery-Tab , EryPed 200), and clarithromycin ( Biaxin ) and ketoconazole ( Nizoral ) can reduce the ability of the liver to metabolize (breakdown) corticosteroids and this may lead to an increase in the levels and side effects of corticosteroids in the body. On the other hand, phenobarbital, ephedrine , phenytoin ( Dilantin ), and rifampin ( Rifadin , Rimactane ) may reduce the blood levels of corticosteroids by increasing the breakdown of corticosteroids by the liver. This may necessitate an increase of corticosteroid dose when they are used in combination with these drugs.

Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma

inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma

Media:

inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthmainhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthmainhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthmainhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthmainhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma